date founded

Financing round

General

About Company
Molecular Devices is a leading provider of high-performance life science technology.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1991

Number of employees

Company Type

For Profit

IPO status

Private

Description

With a wide range of innovative solutions, Molecular Devices enables scientists in academia, pharma, and biotech to improve productivity and accelerate research and development of new therapeutics. Their products have contributed to scientific breakthroughs mentioned in over 230,000 peer-reviewed publications and are utilized in laboratories worldwide. Headquartered in Silicon Valley, Molecular Devices has a global presence and prioritizes collaboration, diversity, and inclusion under the guidance of a diverse leadership team and a female president. To learn more, visit www.moleculardevices.com.
Contacts

Phone number

Social url

Similar Companies
1000
Creoptix

Creoptix

Creoptix develops optical instruments and consumables for label-free analysis of molecular interactions for the drug discovery industry.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Wädenswil, Switzerland

total rounds

2

total raised

$10.73M
Molecular Devices

Molecular Devices

Molecular Devices is a bioanalytical solutions provider that helps customers understand complex biological systems.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Sunnyvale, CA, USA
Axion BioSystems

Axion BioSystems

Axion Biosystems develops technologies that solve problems related to human heart and brain activity.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Atlanta, GA, USA

total rounds

5

total raised

$20.31M
MaxWell Biosystems

MaxWell Biosystems

MaxWell Biosystems is a Swiss company that provides solutions for neuroscience research and preclinical drug discovery.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Basel, Switzerland

total rounds

6

total raised

$4.73M
M&A Details
1

Transaction name

Acquired by

Danaher

announced date

11.01.2010

price

$82M

Financials

Co-Investors

People

Employee Profiles
168

Daniel Detmer

Customer support systems engineer

Melissa Rivas

Senior human resources business partner

Kathleen Haynes

Human resources business partner

Amy Smith

Corporate communications manager

Jayne Hesley

Senior applications scientist and lead customer

Saygbe Biawogi

Senior technical analyst

Shawn Alvarado

Bioimaging sales specialist

Payal Khandelwal

Senior global product manager, biologics business

Activity

Recent News
0